10/20/2026
Psychedelics fast-tracked by FDA under Trump order
Executive order allocates $50 million for psychedelic drug development, including ibogaine.
Topic archive
psychiatry
3 stories
10/7/2026
Ibogaine therapy shows promise for veterans with PTSD
Stanford study finds sustained PTSD relief in veterans a year after ibogaine treatment.
8/18/2026
Puerto Rico advances psychedelic therapy research
Governor's order initiates ibogaine, MDMA, and psilocybin study